Identification and characterization of a C(K/R)TC motif as a common epitope present in all subtypes of hepatitis B surface antigen

Journal of Immunology

Volumn 156, Issue 9, 1996, Pages 3350-3356

  Qiu, Xiaoxing ^a   Schroeder, Pamella ^a   Bridon, Dominique ^a,b  

^a ABBOTT LABORATORIES   (United States)

^b Diagnostic Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYCLOPEPTIDE; CYSTEINE; EPITOPE; HEPATITIS B SURFACE ANTIGEN; MONOCLONAL ANTIBODY; SYNTHETIC PEPTIDE;

AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISULFIDE BOND; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; BINDING SITES, ANTIBODY; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNODOMINANT EPITOPES; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDE FRAGMENTS; SEQUENCE ALIGNMENT; SEROTYPING;

EID: 0029975142     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Szmuness, W. R., C. E. Stevens, E. J. Harley, E. A. Zang, W. R. Oleszko, D. C. William, R. Sadovsky, J. M. Morrison, and A. Kellner. 1980. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N. Engl. J. Med. 303:833.
2. Gerety, R. 1988. Recombinant hepatitis B vaccine. In Viral hepatitis and liver disease, Vol. A. J. Zuckerman, ed. Alan R. Liss, Inc., New York, p. 1017.
3. Decker, R., M. Kuhns, T. Brawner, and L. Mimms. 1988. Future advanced diagnostic techniques for hepatitis B. In Viral hepatitis and liver disease, Vol. A. J. Zuckerman, ed. Alan R. Liss Inc., New York, p. 231.
4. Usuda, S., F. Tsuda, T. Gotanda, K. Tachibana, M. Nomura, H. Okamoto, M. Imai, T. Nakamura, Y. Miyakawa, and M. Mayumi. 1986. A solid-phase enzyme immunoassay for the common and subtypic determinants of hepatitis B surface antigen with monoclonal antibodies. J. Immunol. Methods 87:203.
5. Wands, J., R. I. Carlson, H. Schoemaker, K. J. Isselbacher, and V. R. Zurawski. 1981. Immunodiagnosis of hepatitis B with high-affinity IgM monoclonal antibodies. Proc. Natl. Acad. Sci. USA 78:1214.
6. 125I antibody. Vox Sang. 24:102.
7. Le Bouvier, G. L. 1971. The heterogeneity of Australia antigen. J. Infect. Dis. 123:671.
8. Bancroft, W. H., F. K. Mundon, and P. K. Russell. 1972. Detection of additional antigenic determinants of hepatitis B antigen. J. Immunol. 109:842.
9. Iwarson, S., E. Tabor, H. Thomas, A. Goodall, J. Waters, P. Snoy, J. Shin, and R. Gerety. 1985. Neutralization of hepatitis B virus infectivity by chimpanzee. J. Med. Virol. 16:89.
10. Stirk, H. J., J. M. Thornton, and C. R. Howard. 1992. A topological model for hepatitis B surface antigen. Intervirology 33:148.
11. Vyas, G. N., K. R. Rao, and A. B. Ibrahim. 1972. Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds. Science 178: 1300.
12. Dreesman, G. R., F. B. Hollinger, R. M. McCombs, and J. L. Melnick. 1973. Alteration of hepatitis B antigen (HBAg) determinants by reduction and alkylation. J. Gen. Virol. 19:129.
13. Gerin, J. L., H. Alexander, W.-K. Shih, R. H. Purcell, G. Dapolito, R. Engle, N. Green, J. G. Sutcliffe, T. M. Shinnick, and R. A. Lemer. 1983. Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees. Proc. Natl. Acad. Sci. USA 80:2365.
14. Peterson, D. L., D. A. Paul, J. Lam, I. I. E. Tribby, and D. T. Achord. 1984. Antigenic structure of hepatitis B surface antigen: identification of the "d" subtype determinant by chemical modification and use of monoclonal antibodies. J. Immunol. 132:920.
15. Mimms, L., A. Goetze, S. Swanson, M. Floreani, B. Edwards, J. Macioszek, G. Okasinski, and W. Kiang. 1989. Second generation assays for the detection of antibody to HBsAg using recombinant DNA-derived HBsAg. J. Virol. Methods 25:211.
16. Merrifield, R. B. 1963. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:2149.
17. Tam, J. P., M. A. Sheikh, D. S. Salomon, and L. Ossowski. 1986. Efficient synthesis of human type A transforming growth factor: its physical and biological characterization. Proc. Natl. Acad. Sci. USA 83:8082.
18. Van Heyningen, V. 1986. A simple method for ranking the affinities of monoclonal antibodies. In Methods in Enzymology, Vol. 121. J. J. Langone and H. Van Vunakis, eds. Academic Press, San Diego, p. 472.
19. Dreesman, G. R., Y. Sanchez, I. Ionescu-Matiu, J. T. Sparrow, H. R. Six, D. L. Peterson, F. B. Hollinger, and J. L. Melnick. 1982. Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature 295:158.
20. Bhatnagar, P. K., E. Papas, H. E. Blum, D. R. Milich, D. Nitecki, M. J. Karels, and G. N. Vyas. 1982. Immune response to synthetic peptide analogs of hepatitis B surface antigen specific for the a determinant. Proc. Natl. Acad. Sci. USA 79:4400.
21. Okamoto, H., M. Imai, F. Tsuda, T. Tanaka, Y. Miyakawa, and M. Mayumi. 1987. Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J. Virol. 61:3030.
22. Munson, P. J., and D. Rodbard. 1980. LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:220.
23. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:3099.
24. Wallace, L. A., and W. F. Carman. 1994. Clinical implication of hepatitis B virus envelope protein variation. Int. J. Clin. Lab. Res 24:80.
25. Carman, W., J. Korula, L. Wallace, R. MacPhee, L. Mimms, and R. Decker. 1995. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 345:1406.
26. Lemer, R. A., N. Green, H. Alexander, F.-T. Liu, G. Sutcliffe, and T. M. Shinnick. 1981. Chemically synthesized peptides predicted from the nucleolide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc. Natl. Acad. Sci. USA 78:3403.
27. Prince, A. M., H. Ikram, and T. P. Hopp. 1982. Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide. Proc. Nat. Acad. Sci. USA 79:579.
28. Ohnuma, H., E. Takai, A. Machida, F. Tsuda, H. Okamoto, T. Tanaka, M. Naito, E. Munekata, K. Miki, Y. Miyakawa, and M. Mayumi. 1990. Synthetic oligopeptides bearing a common or subtypic determinant of hepatitis B surface antigen. J. Immunol. 145:2265.
29. Manivel, V., S. K. Panda, and K. V. S. Rao. 1992. Identification of a new group-specific determinant on hepatitis B surface antigen with a synthetic peptide. J. Immunol. 149:2082.
30. Brown, S. E., C. R. Howard, J. J. Zuckerman, and M. W. Steward. 1984. Determination of the affinity of antibodies to hepatitis B surface antigen in human sera. J. Immunol. Methods 72:41.
31. Ionescu-Matiu, I., R. C. Kennedy, J. T. Sparrow, A. R. Culwell, Y. Sanchez, J. L. Melnick, and G. R. Dreesman. 1983. Epitope associated with a synthetic hepatitis B surface antigen peptide. J. Immunol. 130:1947.
32. Motti, C., M. Nuzzo, A. Meola, G. Galfre, F. Felici, R. Cortese, A. Nicosia, and P. Monaci. 1994. Recognition by human sera and immunogenicity of HBsAg mimotopes selected from an M13 phage display library. Gene 146:191.
33. Friedman, A. R., V. A. Roberts, and J. A. Tainer. 1994. Predicting molecular interactions and inducible complementarity: fragment docking of Fab-peptide complexes. Proteins 20:15.
34. Hawkins, R. E., S. J. Russell, M. Baier, and G. Winter. 1993. The contribution of contact and non-contact residues of antibody in the affinity of binding to antigen. J. Mol. Biol. 234:958.
35. Kelley, R. F., and M. P. O'Connell. 1993. Thermodynamic analysis of an antibody functional epitope. Biochemistry 32:6828.
36. Nuss, J. M., P. B. Whitaker, and G. M. Air. 1993. Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase. Proteins 15:121.
37. Jin, L., B. M. Fendly, and J. A. Wells. 1992. High resolution functional analysis of antibody-antigen interactions. J. Mol. Biol. 226:851.
38. Clackson, T., and J. A. Wells. 1995. A hot spot of binding energy in a hormone-receptor interface. Science 267:383.
39. Rao, K. V. S., S. K. Panda, and V. Manive. 1992. Macromolecular self-association of a synthetic peptide derived from the hepatitis B surface antigen: construction of a quaternary epitope. Vaccine 10:204.